Evidence map›Paper›PMID 26494260›Full record

ArticleBioorganic & medicinal chemistry letters2015

Muscarinic acetylcholine receptor binding affinities of pethidine analogs.

Na-Ra Lee, Xuan Zhang, Mahesh Darna, Linda P Dwoskin, Guangrong Zheng

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Na-Ra LeeDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, United States.
Xuan ZhangDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
Mahesh DarnaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, United States.
Linda P DwoskinDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, United States.
Guangrong ZhengDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
University of Kentucky · USUniversity of Arkansas for Medical Sciences · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Development of M5 Selective Muscarinic AntagonistsR21DA030667 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI ZHENG, GUANGRONG · 2011 to 2012
$408k
NCATS NIH HHS UL1 TR000117NIDA NIH HHS DA030667NIDA NIH HHS R21 DA030667
6 · The paper itself

Abstract

A series of pethidine analogs were synthesized and their affinities for the [(3)H]N-methyl-scopolamine (NMS) binding site on muscarinic acetylcholine receptors (mAChRs) were determined using M1, M3 or M5 human mAChRs expressed by Chinese hamster ovary (CHO) cell membranes. Compound 6b showed the highest binding affinities at M1, M3 and M5 mAChRs (Ki=0.67, 0.37, and 0.38 μM, respectively).

Indexed as

AnimalsCHO CellsCricetulusFemaleHumansLigandsMeperidineReceptor, Muscarinic M1Receptor, Muscarinic M3Receptor, Muscarinic M5Structure-Activity RelationshipLigandsMeperidineReceptor, Muscarinic M1Receptor, Muscarinic M3Receptor, Muscarinic M5[(3)H]NMS binding affinityDrug abuseMuscarinic acetylcholine receptorsPethidine

Identifiers

PMID26494260
PMCPMC4629469
OpenAlexW2173942971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.